Navigation Links
Hormone linked to high blood pressure and blood vessel disease in African-Americans

Researchers at The Medical College of Wisconsin in Milwaukee have linked higher levels of the hormone aldosterone to high blood pressure and blood vessel disease in African Americans. Aldosterone is secreted by the adrenal glands and causes salt retention by the kidneys.

The study appeared in the December 18, 2008, American Journal of Hypertension.

"The prevalence of high blood pressure, or hypertension, in African Americans is among the highest in the world," says lead researcher Theodore Kotchen, M.D., professor of medicine and associate dean for clinical research.

"Previously, we found relatively high aldosterone levels in African Americans with high blood pressure," he said. "In this study we have found that aldosterone may not only contribute to high blood pressure but also to related changes in blood vessel function in the kidneys and extremities."

The researchers compared 24-hour blood pressures, heart output, blood vessel stiffness, kidney blood flow, and aldosterone levels in 224 African Americans with high blood pressure, with those of 217 African Americans with normal blood pressure.

They found that those with high blood pressure had higher levels of aldosterone. Their heart output was lower, extremity blood vessel stiffness was greater, kidney blood flow was lower, and kidney resistance to blood flow was higher than those with normal blood pressure.

Most importantly, the blood pressure levels, blood vessel flexibility, and kidney blood flow in those with high blood pressure were all directly correlated with their aldosterone levels.

"These observations suggest that aldosterone contributes to high blood pressure and its related heart, kidney, and blood vessel disease in African Americans," says Dr. Kotchen.


Contact: Toranj Marphetia
Medical College of Wisconsin

Page: 1

Related medicine news :

1. Findings raise new questions about evolution of hormones in mammals
2. Male Hormone Replacement Therapy Optimism for 2009
3. Female Hormones Deter Salt-Sensitive Hypertension
4. 2 Years of Hormone Use May Be Safe
5. Growth hormone treatment after weight loss surgery prevents loss of muscle mass
6. Study identifies potential safe period for hormone replacement use
7. The Truth About Bio-identical Hormone Therapy
8. Tweaking Hormones Might Ease Chronic Stress
9. Hormone-Boosting Drug May Help Treat Frailty
10. AstraZenecas Drug Will Become the New Clinical Gold Standard by 2012 for the Treatment of Metastatic Hormone-Refractory Prostate Cancer
11. Newly Released Book by Retired Scientist Links Self-Control of Hormones to Perfecting One's Life
Post Your Comments:
(Date:11/25/2015)... , ... November 25, 2015 , ... ... has been recognized once again for its stellar workplace culture with the company’s ... , Medical Solutions’ Cincinnati office was named a finalist in Cincinnati ...
(Date:11/25/2015)... (PRWEB) , ... November 26, 2015 , ... ... Union Commission (AUC), European Union (EU), ANDI Pan African Centres of Excellence, and ... Office in Nairobi (UNON) for the opening of the 5th African Network for ...
(Date:11/25/2015)... , ... November 25, 2015 , ... According to an ... robot is being more and more widely heralded as a breakthrough for performing hernia ... method has over traditional laparoscopic surgery is that it can greatly reduce the pain ...
(Date:11/25/2015)... ... November 25, 2015 , ... On November 25, 2015, ... for the Narconon network, announced the release of a new cutting edge recovery program ... organization has been working with drug- and alcohol-addicted individuals with the purpose to free ...
(Date:11/25/2015)... ... , ... On November 23rd 2015 Cozy Products, a division of ... Cozy Products explains what this means for business moving forward. , The Tri Lite ... business model: to sell personal heaters that reduce energy consumption, are economical and keep ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)... , November 25, 2015 ... KTOV ) (TASE: KTOV), a biopharmaceutical company focused on ... of various clinical conditions, today announced the closing of ... Depository Shares ( ADSs ), each representing 20 ordinary ... to 3,158,900 ADSs. The ADSs and warrants were issued ...
(Date:11/25/2015)...  Trovagene, Inc. (NASDAQ: TROV ), a developer ... Officer Antonius Schuh, Ph.D., is scheduled to present a ... Jaffray Healthcare Conference. th Annual Piper ... in New York on Tuesday, ... will be available for one-on-one meetings during the conference. ...
(Date:11/25/2015)... Nov. 25, 2015 Allergan plc (NYSE: ... and Rugen Therapeutics, a start-up  biotechnology company focused ... CNS disorders and funded by the F-Prime Biomedical ... entered into an exclusive collaboration to support the ... Spectrum Disorders (ASD) and Obsessive Compulsive disorders (OCD). ...
Breaking Medicine Technology: